What question did this study set out to answer?

To analyze the association between trough anti-Xa measurement of dalteparin and bleeding incidents in patients with kidney impairment.

March 14, 2026Open Access

A Service Evaluation of Anti-Xa Measurements in Patients with Kidney Impairment in A Tertiary Centre

Key Points

To analyze the association between trough anti-Xa measurement of dalteparin and bleeding incidents in patients with kidney impairment.
Assessment of anti-Xa levels in patients with chronic kidney disease (CKD)
Evaluation of bleeding incidents associated with anticoagulation treatment
Service evaluation conducted in a tertiary care setting.
Anti-Xa measurement is independently associated with bleeding in CKD patients.
Current findings warrant larger prospective studies for validation.

Abstract

In this report, trough anti-Xa measurement of dalteparin is independently associated with bleeding in patients with CKD. Further prospective, larger studies are warranted to validate these results before it can be universally recommended in clinical practice.

Read Full Paperexternally

AI에게 질문

Bookmark

View Full Paper

Cite This Study

Gurumurthy et al. (Wed,) studied this question.

synapsesocial.com/papers/69b4ad8d18185d8a398010b2 https://doi.org/https://doi.org/10.1159/000551515

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

AI에게 질문

Bookmark

View Full Paper